Cure Today5d
FDA Accepts sNDA for Welireg in Advanced Pheochromocytoma and Paraganglioma
The FDA has accepted a priority review sNDA for Welireg in adults and pediatric patients with advanced or metastatic pheochromocytoma and paraganglioma.
Targeted Oncology6d
FDA Grants Belzutifan Priority Review For Advanced Pheochromocytoma and Paraganglioma
The FDA granted priority review for belzutifan for treating advanced pheochromocytoma and paraganglioma, with a PDUFA date set for May 26, 2025.
Endocrinology Advisor6d
Belzutifan Gets Priority Review for Advanced Pheochromocytoma and Paraganglioma
The FDA has accepted the application for belzutifan for advanced, unresectable, or metastatic pheochromocytoma and paraganglioma.
Contract Pharma7d
Merck’s WELIREG Accepted for Priority Review by FDA for Pheochromocytoma and Paraganglioma
The supplemental new drug application is based on data from the Phase 2 LITESPARK-015 trial.
Women's Health27d
Norovirus Is Surging Across The Country. Here Are The Symptoms To Look For, Per Infectious Disease Doctors
Here’s what you need to know about symptoms of norovirus, plus what to do if you’re unlucky enough to get it. Meet the expert: Infectious disease expert Amesh A. Adalja, MD, is a senior ...
Self28d
CDC Data Shows Norovirus Is Surging—Here Are 5 Symptoms You Really Shouldn’t Ignore
If you buy something, we may earn an affiliate commission. If there’s one thing you don’t want to endure, it’s the symptoms of norovirus, a brutal stomach bug that tends to cause relentless ...